These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. Wirblich C; Coleman CM; Kurup D; Abraham TS; Bernbaum JG; Jahrling PB; Hensley LE; Johnson RF; Frieman MB; Schnell MJ J Virol; 2017 Jan; 91(2):. PubMed ID: 27807241 [TBL] [Abstract][Full Text] [Related]
11. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies. Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P Front Immunol; 2020; 11():2130. PubMed ID: 33013898 [TBL] [Abstract][Full Text] [Related]
12. A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development. Castanha PMS; Marques ETA Viruses; 2020 Nov; 12(12):. PubMed ID: 33266129 [TBL] [Abstract][Full Text] [Related]
13. Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV). Zumla A; Alagaili AN; Cotten M; Azhar EI BMC Med; 2016 Sep; 14(1):132. PubMed ID: 27604081 [TBL] [Abstract][Full Text] [Related]
15. Challenges of Vaccine Development for Zika Virus. Blackman MA; Kim IJ; Lin JS; Thomas SJ Viral Immunol; 2018 Mar; 31(2):117-123. PubMed ID: 29227202 [TBL] [Abstract][Full Text] [Related]
17. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus. Garg H; Sedano M; Plata G; Punke EB; Joshi A J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019 [TBL] [Abstract][Full Text] [Related]
18. Detecting Emerging Infectious Diseases: An Overview of the Laboratory Response Network for Biological Threats. Villanueva J; Schweitzer B; Odle M; Aden T Public Health Rep; 2019; 134(2_suppl):16S-21S. PubMed ID: 31682559 [TBL] [Abstract][Full Text] [Related]
19. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges. Cho H; Excler JL; Kim JH; Yoon IK Hum Vaccin Immunother; 2018 Feb; 14(2):304-313. PubMed ID: 29048984 [TBL] [Abstract][Full Text] [Related]
20. Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates. Vannice KS; Cassetti MC; Eisinger RW; Hombach J; Knezevic I; Marston HD; Wilder-Smith A; Cavaleri M; Krause PR Vaccine; 2019 Feb; 37(6):863-868. PubMed ID: 30639461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]